High-throughput discovery of novel small-molecule inhibitors of acid Ceramidase

Abstract Ceramide has a key role in the regulation of cellular senescence and apoptosis. As Ceramide levels are lowered by the action of acid ceramidase (AC), abnormally expressed in various cancers, the identification of AC inhibitors has attracted increasing interest. However, this finding has been mainly hampered by the lack of formats suitable for the screening of large libraries. We have overcome this drawback by adapting a fluorogenic assay to a 384-well plate format. The performance of this optimised platform has been proven by the screening a library of 4100 compounds. Our results show that the miniaturised platform is well suited for screening purposes and it led to the identification of several hits, that belong to different chemical classes and display potency ranges of 2–25 µM. The inhibitors also show selectivity over neutral ceramidase and retain activity in cells and can therefore serve as a basis for further chemical optimisation.

[1]  T. Hornemann,et al.  Discovery and mechanism of action of small molecule inhibitors of ceramidases. , 2021, Angewandte Chemie.

[2]  T. Hornemann,et al.  Discovery and mechanism of action of small molecule inhibitors of ceramidases , 2021, bioRxiv.

[3]  J. Casas,et al.  Discovery of deoxyceramide analogs as highly selective ACER3 inhibitors in live cells. , 2021, European journal of medicinal chemistry.

[4]  Young‐Tae Chang,et al.  Click and count: specific detection of acid ceramidase activity in live cells† , 2020, Chemical science.

[5]  Y. Hannun,et al.  Identification of Small-Molecule Inhibitors of Neutral Ceramidase (nCDase) via Target-Based High-Throughput Screening , 2020, SLAS discovery : advancing life sciences R & D.

[6]  E. Bongarzone,et al.  Lead Optimization of Benzoxazolone Carboxamides as Orally Bioavailable and CNS Penetrant Acid Ceramidase Inhibitors , 2020, Journal of medicinal chemistry.

[7]  J. Brüning,et al.  The role of ceramides in metabolic disorders: when size and localization matters , 2020, Nature Reviews Endocrinology.

[8]  Yadira F. Ordóñez,et al.  Activity-Based Imaging of Acid Ceramidase in Living Cells. , 2019, Journal of the American Chemical Society.

[9]  J. Casas,et al.  New fluorogenic probes for neutral and alkaline ceramidases[S] , 2019, Journal of Lipid Research.

[10]  Yancun Yin,et al.  Alkaline ceramidase 3 promotes growth of hepatocellular carcinoma cells via regulating S1P/S1PR2/PI3K/AKT signaling. , 2018, Pathology, research and practice.

[11]  Shama P. Mirza,et al.  Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency , 2017, Oncotarget.

[12]  Y. Hannun,et al.  Role of neutral ceramidase in colon cancer , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  C. Arenz,et al.  Inhibitors of Ceramidases. , 2016, Chemistry and physics of lipids.

[14]  C. Chen,et al.  ACER3 supports development of acute myeloid leukemia. , 2015, Biochemical and biophysical research communications.

[15]  D. Piomelli,et al.  Benzoxazolone Carboxamides as Potent Acid Ceramidase Inhibitors: Synthesis and Structure-Activity Relationship (SAR) Studies. , 2015, Journal of medicinal chemistry.

[16]  D. Piomelli,et al.  Benzoxazolone Carboxamides: Potent and Systemically Active Inhibitors of Intracellular Acid Ceramidase** , 2014, Angewandte Chemie.

[17]  Sarah Spiegel,et al.  Sphingolipid metabolites in inflammatory disease , 2014, Nature.

[18]  Maria Paola Costi,et al.  Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity , 2013, Scientific Reports.

[19]  H. Vinters,et al.  Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases. , 2012, Journal of Alzheimer's disease : JAD.

[20]  M. Cabot,et al.  Inhibition of acid ceramidase by a 2‐substituted aminoethanol amide synergistically sensitizes prostate cancer cells to N‐(4‐hydroxyphenyl) retinamide , 2011, The Prostate.

[21]  C. Bedia,et al.  Acid Ceramidase Expression Modulates the Sensitivity of A375 Melanoma Cells to Dacarbazine* , 2011, The Journal of Biological Chemistry.

[22]  A. Bielawska,et al.  Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  L. Obeid,et al.  Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. , 2008, Biochimica et biophysica acta.

[24]  A. Bielawska,et al.  The functional effects of acid ceramidase over-expression in prostate cancer progression and resistance to chemotherapy , 2007, Cancer biology & therapy.

[25]  C. Bedia,et al.  Synthesis of a Novel Ceramide Analogue and its Use in a High‐Throughput Fluorogenic Assay for Ceramidases , 2007, Chembiochem : a European journal of chemical biology.

[26]  Yusuf A. Hannun,et al.  Biologically active sphingolipids in cancer pathogenesis and treatment , 2004, Nature Reviews Cancer.

[27]  F. Martinelli-Boneschi,et al.  Ceramide levels are inversely associated with malignant progression of human glial tumors , 2002, Glia.

[28]  Yusuf A. Hannun,et al.  The Ceramide-centric Universe of Lipid-mediated Cell Regulation: Stress Encounters of the Lipid Kind* , 2002, The Journal of Biological Chemistry.

[29]  H. Wanebo,et al.  Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line , 2000, Cancer Chemotherapy and Pharmacology.

[30]  J. Park,et al.  A fluorescence-based high-performance liquid chromatographic assay to determine acid ceramidase activity. , 1999, Analytical biochemistry.

[31]  Craig R Moores,et al.  H-40, an antigen controlled by an Igh linked gene and recognized by cytotoxic T lymphocytes. I. Genetic analysis of H-40 and distribution of its product on B cell tumors , 1984, The Journal of experimental medicine.